0
0
0
Affordable Drug Manufacturing Act of 2019
10/28/2022, 1:46 AM
Congressional Summary of HR 5501
Affordable Drug Manufacturing Act of 2019
This bill establishes the Office of Drug Manufacturing within the Department of Health and Human Services to lower prices for, increase access to, and address shortages of prescription drugs (e.g., insulin, naloxone, and antibiotics), including by manufacturing prescription drugs and selling them at a fair price.
Read the Full Bill
Current Status of Bill HR 5501
Bill HR 5501 is currently in the status of Bill Introduced since December 19, 2019. Bill HR 5501 was introduced during Congress 116 and was introduced to the House on December 19, 2019. Bill HR 5501's most recent activity was Referred to the Subcommittee on Health. as of December 20, 2019
Bipartisan Support of Bill HR 5501
Total Number of Sponsors
1Democrat Sponsors
1Republican Sponsors
0Unaffiliated Sponsors
0Total Number of Cosponsors
0Democrat Cosponsors
0Republican Cosponsors
0Unaffiliated Cosponsors
0Policy Area and Potential Impact of Bill HR 5501
Primary Policy Focus
HealthPotential Impact Areas
- Competition and antitrust
- Congressional oversight
- Department of Health and Human Services
- Drug safety, medical device, and laboratory regulation
- Executive agency funding and structure
- Federal officials
- Government employee pay, benefits, personnel management
- Health care costs and insurance
- Health care coverage and access
- Health care quality
- Health programs administration and funding
- Inflation and prices
- Licensing and registrations
- Manufacturing
- Prescription drugs
- Public contracts and procurement
- Public participation and lobbying
Alternate Title(s) of Bill HR 5501
Affordable Drug Manufacturing Act of 2019
To amend the Public Health Service Act to establish an Office of Drug Manufacturing.
Affordable Drug Manufacturing Act of 2019
Comments
Sponsors and Cosponsors of HR 5501
Latest Bills
Financial Reporting Threshold Modernization Act
Bill HR 1799January 24, 2026
Expressing support for the designation of May 2025 as "Renewable Fuels Month" to recognize the important role that renewable fuels play in reducing carbon impacts, lowering fuel prices for consumers, supporting rural communities, and lessening reliance on foreign adversaries.
Bill HRES 375January 24, 2026
Empower Charter School Educators to Lead Act
Bill HR 3453January 24, 2026
Star-Spangled Summit Act of 2025
Bill HR 4684January 23, 2026
Cross-Boundary Wildfire Solutions Act
Bill HR 3922January 23, 2026
Whole Milk for Healthy Kids Act of 2025
Bill S 222January 23, 2026
Retire through Ownership Act
Bill HR 5169January 23, 2026
No Tax on Home Sales Act
Bill HR 4327January 23, 2026
MAWS Act of 2025
Bill HR 4294January 23, 2026
Enhanced Iran Sanctions Act of 2025
Bill HR 1422January 23, 2026
Affordable Drug Manufacturing Act of 2020
Bill S 3162February 8, 2022